我在做学生时,很难记住抗心律失常药物的分类,因为它们有几十种。而现在我只把它们分为胺碘酮与非胺碘酮两类。——英国心脏协会主席Camm(图1)众所周知,胺碘酮做为一个广谱抗心律失常药物临床应用已30年。在30年的应用中胺碘酮不仅久盛不衰,而且还在不断推出应用的新特点、作用的新机制。在欧美国家,胺碘酮占抗心律失常药物处方量的1/3,而拉美国家竟高达70%。相比之下,中国胺碘酮的应用尚不够广泛,约占抗心律失常药物总处 When I was a student, it was hard to remember the class of antiarrhythmic drugs because they had dozens of them. Now I just classify them into amiodarone and non-amiodarone. - Camm, chairman of the British Heart Association (Figure 1) It is well-known that amiodarone has been used clinically for 30 years as a broad-spectrum antiarrhythmic drug. Amiodarone is not only long-lasting in 30 years of use, but is still being introduced as a new mechanism for the application of new features and functions. In Europe and the United States, amiodarone accounted for 1/3 of anti-arrhythmic drug prescriptions, while Latin American countries actually as high as 70%. In contrast, the application of amiodarone in China is not yet widespread enough, accounting for the total anti-arrhythmic drugs